정맥주사(IV) 장비 시장 규모 - 제품별, 최종 용도별 및 세계 예측(2023-2032년)

Global Intravenous (IV) Equipment Market will witness 6.7% CAGR between 2023 and 2032. Surging incidences of non-communicable diseases, in line with a consistent rise in the aging population, have boosted the demand for IV therapies and treatments. According to September 2023 statistics from the WHO, each year, non-communicable diseases (NCDs) or chronic diseases claim the lives of 41 million individuals, accounting for 74% of all worldwide fatalities.

Technological advancements in IV equipment enhance safety and patient comfort, driving product adoption. Furthermore, The COVID-19 pandemic highlighted the importance of IV equipment in critical care settings, further fueling market growth. The rising preference for home-based healthcare and the expanding healthcare infrastructure in emerging markets contribute to the growth of intravenous IV equipment market size.

The overall Intravenous (IV) Equipment Market is classified based on product, end-use, and region.

The administration sets segment will undergo significant development from 2023 to 2032. These crucial components ensure precise medication delivery and fluid administration, making them vital in healthcare settings. As patient care becomes increasingly individualized, the need for advanced administration sets with features like flow control and anti-infection measures rises. The administration sets segment of the intravenous IV equipment market continues to grow in response to evolving healthcare demands.

The diagnostic centers segment will register a commendable CAGR from 2023 to 2032. IV equipment is essential for various medical procedures, including contrast-enhanced imaging and diagnostic testing. As diagnostic centers prioritize patient comfort and precise medication delivery, the demand for advanced IV equipment, such as infusion pumps and catheters, is on the rise. This trend ensures accurate diagnoses and enhanced patient experiences, positioning IV equipment as a critical component in diagnostic centers.

Europe intravenous (IV) equipment market will showcase an appreciable CAGR from 2023 to 2032. The region's robust healthcare infrastructure, alongside the increasing healthcare expenditure, drives the need for advanced IV equipment. The growing aging population contributes to the sustained demand for IV equipment in Europe, making it a prominent market segment within the healthcare industry. According to Eurostat, in 2022, over one-fifth, specifically 21.1%, of the European Union's population was 65 years of age or older. Moreover, European countries emphasize patient care, leading to the adoption of innovative IV solutions for precise medication delivery and fluid administration, further contributing to market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & calculations
• 1.3 Forecast calculations
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Intravenous equipment (IV) industry 360 degree synopsis, 2018 - 2032
• 2.2 Regional trends (Revenue & Volume)
• 2.3 Product trends (Revenue & Volume)
• 2.4 End-use trends

Chapter 3 Intravenous Equipment Industry Insights

• 3.1 Impact on COVID-19
• 3.2 Industry ecosystem analysis
• 3.3 Technology & innovation landscape
• 3.4 Regulatory landscape
• 3.5 Industry impact forces
  • 3.5.1 Growth drivers
    • 3.5.1.1 Increasing demand for ambulatory infusion pumps
    • 3.5.1.2 Rising prevalence of chronic disease
    • 3.5.1.3 High surge in surgical procedures
    • 3.5.1.4 Technological advancements regarding IV equipment
  • 3.5.2 Industry pitfalls & challenges
    • 3.5.2.1 Medical errors associated with IV equipment
    • 3.5.2.2 Stringent regulatory framework
• 3.6 Growth potential analysis
  • 3.6.1 By product
  • 3.6.2 By end-use
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive landscape, 2022

• 4.1 Introduction
• 4.2 Company market share analysis, 2022
• 4.3 Competitive analysis of major market players
  • 4.3.1 B. Braun Melsungen AG
  • 4.3.2 3M
  • 4.3.3 Terumo Corporation
• 4.4 Competitive positioning matrix
• 4.5 Strategic outlook matrix

Chapter 5 Intravenous Equipment Market Estimates and Forecast, By Product (Revenue & Volume)

• 5.1 Key trends, by product
• 5.2 IV catheters
• 5.3 Administration sets
• 5.4 Infusion pumps
• 5.5 Securement devices
• 5.6 Drip chambers
• 5.7 Stopcocks and check valves
• 5.8 Needless connectors
• 5.9 Others

Chapter 6 Intravenous Equipment Market Estimates and Forecast, By End-use (Revenue)

• 6.1 Key trends, by end-use
• 6.2 Hospitals and clinics
• 6.3 Diagnostic centers
• 6.4 Ambulatory surgical centers
• 6.5 Others

Chapter 7 Intravenous Equipment Market Estimates and Forecast, By Region (Revenue & Volume)

• 7.1 Key trends, by region
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Italy
  • 7.3.5 Spain
  • 7.3.6 Switzerland
  • 7.3.7 The Netherlands
  • 7.3.8 Denmark
  • 7.3.9 Poland
  • 7.3.10 Sweden
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
  • 7.4.6 New Zealand
  • 7.4.7 Vietnam
  • 7.4.8 Indonesia
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
  • 7.5.4 Colombia
  • 7.5.5 Chile
• 7.6 Middle East & Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 South Africa
  • 7.6.3 UAE
  • 7.6.4 Turkey

Chapter 8 Company Profiles

• 8.1 B. Braun Melsungen AG
• 8.2 3M
• 8.3 Terumo Corporation
• 8.4 Abbott
• 8.5 Teleflex Incorporated
• 8.6 BD
• 8.7 Henry Schein, Inc.
• 8.8 Smiths Medical
• 8.9 Baxter
• 8.10 Ascor S.A.
• 8.11 Moog Inc.
• 8.12 AngioDynamics
• 8.13 ICU Medical, Inc.
• 8.14 Fresenius SE & Co. KGaA
• 8.15 Animas LLC
• 8.16 Arcomed ag
• 8.17 International WIN, LTD